-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Maintains Buy on GE HealthCare Techs, Lowers Price Target to $81

Benzinga·04/09/2026 17:43:32
Listen to the news
Goldman Sachs analyst David Roman maintains GE HealthCare Techs (NASDAQ:GEHC) with a Buy and lowers the price target from $97 to $81.